Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1986-12-05
1989-11-07
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
424 89, 530324, 530325, 530326, 530327, 530328, 530329, 435 7, 435810, G01N 33569, A61K 3912
Patent
active
048792136
ABSTRACT:
A synthetic polypeptide that contains about 6 to about 40 amino acid residues that immunologically mimics the early antigen-diffuse (EA-D) protein of the Epstein-Barr virus (EBV) is disclosed, as are receptors raised to that polypeptide, methods of their use and a reagent system. A polypeptide of the present invention has an amino acid residue sequence that corresponds to the sequence of the EBV EA-D protein from about position 350 to about position 362 from the amino-terminus.
REFERENCES:
patent: 4654419 (1987-03-01), Vaughan et al.
patent: 4707358 (1987-11-01), Kieff et al.
Green et al., Cell, 28:477-487 (1982).
A. L. Lehninger, Biochemistry, pp. 57-58, Worth Publishers, Inc., 1975.
Henle et al., "Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus", Science, 169 (1970) 188-190.
Cho et al., "Localization of the Coding Region for an Epstein-Barr Virus Early Antigens and Inducible Expression of this 60-Kilodalton Nuclear Protein in Transfected Fibroblast Cell Lines", J. Virol. 56 (1985), 852-859.
Baer et al., "DNA Sequence and Expression of the B95-8 Epstein-Barr Virus Genome", Nature, 310 (1984) 207-211.
Halprin et al., "Enzyme-Linked Immunosorbent Assay of Antibodies to Epstein-Barr Virus Nuclear and Early Antigens in Patients with Infectious Mononucleosis and Nasopharyngeal Carcinoma", Ann. Int. Med. 104 (1986) 331-7.
Pearson et al., "Identification of Polypeptide Components of the Epstein-Barr Virus Early Antigen Complex with Monoclonal Antibodies", J. Virol. 47 (1983) 193-201.
Luka et al., "A Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Against the Major EBV-Associated Antigens. I. Correlation Between ELISA and Immunofluorescence Titers Using Purified Antigens", J. Immunol. Meth., 67 (1984) 145-156.
Rhodes et al., "Human Immune Responses to Synthetic Peptides from the Epstein-Barr Nuclear Antigen", J. Immunol., 134 (1985) 211-216.
Glaser et al., "Functional Mapping of the Esptein-Barr Virus Genome: Identification of Sites Coding for the Restricted Early Antigen, the Diffuse Early Antigen, and the Nuclear Antigen", Virol. 129 (1983) 188-198.
Cho et al., "Epstein-Barr Virus (P3HR-1) Defective DNA Codes for Components of Both the Early Antigen and Viral Capsid Antigen Complexes", Virol., 137 (1984) 9-19.
Dolken et al., "Characterization of the Epstein-Barr Virus-Induced Early Polypeptide Complex p50/58 EA-D Using Rabbit Antisera, a Monoclonal Antibody, and Human Antibodies", Virol., 157 (1987) 460-471.
Wong et al., "Identification and Mapping of Epstein-Barr Virus Early Antigens and Demonstration of a Viral Gene Activator that Functions in Trans", J. Virol., 60 (1986) 149-156.
Fox Robert I.
Houghton Richard
Nucker Christine M.
Scripps Clinic and Research Foundation
LandOfFree
Synthetic polypeptides and antibodies related to Epstein-Barr vi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic polypeptides and antibodies related to Epstein-Barr vi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic polypeptides and antibodies related to Epstein-Barr vi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-83345